They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Scientists have tested a new drug therapy in diabetic mice, and found that it boosted insulin-producing cells by 700% over three months, effectively reversing their disease.

rs6190 helps men build muscle mass and reduce diabetes risk, but increases cholesterol levels and elevates the risk of ...

If insulin can’t get out of blood vessels, it can’t act in its target tissues. “Endothelial cells are full of insulin receptors,” says Stefan Offermanns, who led the study.

During animal development, cells divide and arrange themselves in a coordinated way, eventually forming the embryo. The cells ...

New stem cell therapy offers hope for type 1 diabetes, freeing patients from insulin. Learn why diverse clinical trial ...

Researchers from the University of British Columbia (UBC) have uncovered a direct connection between high insulin ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets to treat obesity and metabolic diseases.

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, multiple sclerosis, shows a new study in mice.

Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...